Altogether, these data allow us to propose a scenario in which intestinal ɣδ T cells could be activated in a TcR-dependent manner, most likely by metabolites derived from inulin-mediated remodeling of the microbiota and then recirculated to the tumor to promote CD8+ T cell anti-tumor activity. The gene discussed is CD8A; the disease is neoplasm.